Can You Have PMS or Hormone Symptoms with Normal Hormone Labs?

Short answer: yes.

One of the most common questions I hear in practice is:

“If my hormone labs are normal, does that mean my hormones aren’t causing my symptoms?”

Not necessarily.

People often come in experiencing symptoms that feel very hormonal:

• mood changes

• irritability or anxiety before periods

• breast tenderness

• bloating

• sleep changes

• headaches

• changes in energy or concentration

Then hormone testing comes back “normal.”

That can feel frustrating—or even invalidating.

But normal hormone labs do not automatically mean your symptoms are not real, not important, or unrelated to hormonal physiology.

What hormone testing is actually good at

Hormone testing can be very useful—but only when we understand what question we are trying to answer.

Depending on the clinical situation, hormone testing may help evaluate:

• whether the ovaries appear to be functioning as expected

• whether ovulation may be occurring

• whether hormone levels are broadly appropriate for age and reproductive stage

• whether there are signs of conditions that warrant further assessment

Laboratory testing can absolutely have value.

But many people expect hormone testing to answer a different question:

“Why do I feel this way?”

And often, hormone testing cannot fully answer that.

Why normal hormone labs don’t always explain PMS symptoms

Hormones are not static.

Across a normal menstrual cycle, estrogen and progesterone rise and fall substantially. Those fluctuations are expected physiology.

Research over several decades suggests that people with PMS and PMDD do not consistently have abnormal circulating estrogen or progesterone levels compared with people without symptoms (Andersch et al., 1979; Taylor, 1979).

Instead, current models suggest that for at least some people, symptoms may relate more to how the brain and body respond to normal hormonal fluctuations than to having hormone levels outside expected ranges (Hantsoo & Epperson, 2015).

In PMDD specifically, emerging evidence points toward altered sensitivity to ovarian steroid changes and differences in neuroactive steroid signalling—particularly involving allopregnanolone and GABA-A receptor responses across the menstrual cycle (Hantsoo & Epperson, 2020; Martinez et al., 2016).

That means two things can be true at the same time:

Your labs may look normal, AND your symptoms may still deserve treatment.

Can you have PMS or PMDD with normal hormone testing?

Yes.

Current diagnostic approaches for PMS and PMDD do not rely on finding abnormal estrogen or progesterone levels.

In fact, expert guidance emphasizes that laboratory testing should generally be limited and diagnosis should focus primarily on:

• symptom history

• timing within the menstrual cycle

• exclusion of other conditions where appropriate

• prospective symptom tracking (O’Brien et al., 2011; ACOG Clinical Practice Guideline No. 7, 2023).

Tracking symptoms over time is often more informative than a single hormone measurement.

What should happen if symptoms persist?

Good hormone care is not about choosing between symptoms or labs.

It is about integrating both.

Your clinician should help answer questions like:

• Does testing meaningfully change management?

• Do symptoms fit a cyclical pattern?

• Are there other diagnoses to consider?

• What outcomes matter most to you?

• What treatment options fit your values and goals?

Shared decision-making matters here.

Because sometimes the next step is additional evaluation.

Sometimes it is symptom tracking.

And sometimes treatment decisions are made even when laboratory values are reassuring.

The bottom line

Normal hormone labs do not automatically invalidate hormonal symptoms.

Labs matter.

Symptoms matter.

And good care recognizes that understanding hormone health often requires looking beyond a single blood test.

References

Andersch B, Abrahamsson L, Wendestam C, et al. Hormone profile in premenstrual tension: effects of bromocriptine and diuretics. Clin Endocrinol (Oxf). 1979;11:657–664.

Taylor JW. Plasma progesterone, oestradiol 17 beta and premenstrual symptoms. Acta Psychiatr Scand. 1979;60:76–80.

Hantsoo L, Epperson CN. Premenstrual Dysphoric Disorder: Epidemiology and Treatment. Curr Psychiatry Rep. 2015;17(11):87.

Hantsoo L, Epperson CN. Allopregnanolone in premenstrual dysphoric disorder (PMDD): Evidence for dysregulated sensitivity to GABA-A receptor modulating neuroactive steroids across the menstrual cycle. Neurobiology of Stress. 2020;12.

Martinez PE, Rubinow DR, Nieman LK, et al. 5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder. Neuropsychopharmacology. 2016;41:1093–1102.

O’Brien PMS, Bäckström T, Brown C, et al. Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: The ISPMD Montreal consensus. Arch Womens Ment Health. 2011;14:13–21.

Management of Premenstrual Disorders: ACOG Clinical Practice Guideline No. 7. Obstet Gynecol. 2023;142:1516.